PPIF and breast carcinoma: We found that female Ppif−/− mice, but not their Ripk3−/− or Mlkl−/− counterparts, develop M/D-driven mammary carcinomas with a shorter delay than wild-type (WT) mice at both primary and secondary disease sites, resulting in reduced overall survival despite a comparable growth of established tumors.